aTyr Pharma
ATYR
50 hedge funds and large institutions have $152M invested in aTyr Pharma in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
9% more funds holding
Funds holding: 46 → 50 (+4)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
42% less capital invested
Capital invested by funds: $262M → $152M (-$110M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$6.72M |
| 2 |
JP Morgan Chase
New York
|
+$2.9M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.78M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.01M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$746K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$2.5M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$1.09M |
| 3 |
MIG
Mariner Investment Group
Harrison,
New York
|
-$938K |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$381K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$318K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| – | -$13.9K | -61 | -97% |
|
52
Wells Fargo
San Francisco,
California
| – | -$4.56K | -20 | -91% |
|
53
Invesco
Atlanta,
Georgia
| – | -$5K | -18 | Closed |
|
54
Bank of America
Charlotte,
North Carolina
| – | -$2.51K | -11 | -92% |
|
ATYR Hedge Fund Activity: Q3 2015 in Review
50 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in aTyr Pharma (ATYR) for Q3 2015, worth a combined $152M — down 42% from $262M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ATYR positions and 4 closed out — a net gain of 4 holders — while 15 added to existing stakes and 14 trimmed.
The largest buyer was RS Investment Management, adding an estimated $6.72M. The largest seller was BVF Inc, exiting entirely with an estimated $2.5M sold.
- 50 institutional investors held aTyr Pharma (ATYR) as of Q3 2015, up from 46 in Q2 2015.
- Funds reported $152M of aTyr Pharma stock for Q3 2015, down 42% quarter-over-quarter.
- 8 funds opened new aTyr Pharma positions in Q3 2015 and 4 closed out, a net change of +4 holders.
- The largest aTyr Pharma buyer in Q3 2015 was RS Investment Management, an estimated $6.72M added.
- The largest aTyr Pharma seller in Q3 2015 was BVF Inc, an estimated $2.5M sold.
Based on aggregated 13F filings for Q3 2015.